Stay updated on RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.

Latest updates to the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page
- Check5 days agoChange DetectedAdded multiple future dates to the page and removed several earlier dates, signaling updated scheduling/timing information.SummaryDifference0.6%
- Check12 days agoChange DetectedUpdated notice about funding status and updated to v3.2.0 (replacing v3.1.0).SummaryDifference3%
- Check20 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdds new release notes for v3.0.2 with recent dates and an estimated update label, and removes older July entries and the old v3.0.1 notes to focus on the current release and streamline the history.SummaryDifference0.7%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated to include new drug information for omaveloxolone and additional resources related to various diseases, while some specific location details and previous genetic resources have been removed.SummaryDifference3%
Stay in the know with updates to RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.